Glyceraldehyde-3-Phosphate Dehydrogenase-Monoamine Oxidase B-Mediated Cell Death-Induced by Ethanol is Prevented by Rasagiline and 1-R-Aminoindan

Neurotoxicity Research

Volumn 16, Issue 2, 2009, Pages 148-159

  Ou, Xiao Ming ^a   Lu, Deyin ^a   Johnson, Chandra ^a   Chen, Kevin ^b   Youdim, Moussa B H ^d   Rajkowska, Grazyna ^a   Shih, Jean C ^b,c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Alcohol use disorders; Apoptosis; Brain cell lines; Glyceraldehyde 3 phosphate dehydrogenase; MAO B inhibitors; Monoamine oxidase B; The metabolite of rasagiline; Transforming growth factor beta inducible early gene 2

Indexed keywords

1 AMINOINDAN; ALCOHOL; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROGEN PEROXIDE; MONOAMINE OXIDASE B INHIBITOR; RASAGILINE; SELEGILINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA INDUCIBLE EARLY GENE 2; UNCLASSIFIED DRUG;

ALCOHOLISM; ARTICLE; BRAIN NERVE CELL; CATALYSIS; CELL DEATH; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; ETHANOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; HYDROGEN PEROXIDE; IMMUNOPRECIPITATION; INDANS; MONOAMINE OXIDASE; NEUROPROTECTIVE AGENTS; PROTEIN TRANSPORT; REPRESSOR PROTEINS; RNA, SMALL INTERFERING;

EID: 70449518337     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-009-9064-7     Document Type: Article

References (49)

1. ED Adickes TJ Mollner SK Lockwood 1988 Closed chamber system for delivery of ethanol to cell cultures Alcohol Alcohol 23 377 381 3228458 1:STN:280:DyaL1M7kvFykug%3D%3D
2. K Alexander-Kaufman G James D Sheedy C Harper I Matsumoto 2006 Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study Mol Psychiatry 11 56 65 16172612 10.1038/sj.mp.4001741 1:CAS:528:DC%2BD2MXhtlSksrnK (Pubitemid 43251088)
3. KS Ansari PH Yu TP Kruck WG Tatton 1993 Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition J Neurosci 13 4042 4053 8366359 1:CAS:528:DyaK2cXmvFemsg%3D%3D
4. BI Bae MR Hara MB Cascio CL Wellington MR Hayden CA Ross HC Ha XJ Li SH Snyder A Sawa 2006 Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH Proc Natl Acad Sci U S A 103 3405 3409 16492755 10.1073/pnas.0511316103 1:CAS:528:DC%2BD28XksF2kurg%3D (Pubitemid 43346481)
5. O Bar-Am T Amit MB Youdim 2007 Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro J Neurochem 103 500 508 17635668 10.1111/j.1471-4159.2007. 04777.x 1:CAS:528:DC%2BD2sXht1KqsLzP (Pubitemid 47498024)
6. F Blandini 2005 Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease? CNS Drug Rev 11 183 194 16007239 1:CAS:528: DC%2BD2MXhtVOlsbbF
7. F Blandini MT Armentero R Fancellu E Blaugrund G Nappi 2004 Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease Exp Neurol 187 455 459 15144871 10.1016/j.expneurol.2004.03.005 1:CAS:528:DC%2BD2cXktV2lsL0%3D (Pubitemid 38610291)
8. GW Carlile RM Chalmers-Redman NA Tatton A Pong KE Borden WG Tatton 2000 Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer Mol Pharmacol 57 2 12 10617673 1:CAS:528:DC%2BD3cXhslCmug%3D%3D
9. A Carlsson R Adolfsson SM Aquilonius CG Gottfries L Oreland L Svennerholm B Winblad 1980 Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism Adv Biochem Psychopharmacol 23 295 304 6156586 1:CAS:528:DyaL3cXksVegsr4%3D
10. H Checkoway K Powers T Smith-Weller GM Franklin WT Longstreth Jr PD Swanson 2002 Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake Am J Epidemiol 155 732 738 11943691 10.1093/aje/155.8.732 (Pubitemid 34297653)
11. DM Chuang C Hough VV Senatorov 2005 Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases Annu Rev Pharmacol Toxicol 45 269 290 15822178 10.1146/annurev.pharmtox.45.120403.095902 1:CAS:528:DC%2BD2MXisVWjt7s%3D (Pubitemid 40261806)
12. T Cook R Urrutia 2000 TIEG proteins join the Smads as TGF-beta-regulated transcription factors that control pancreatic cell growth Am J Physiol Gastrointest Liver Physiol 278 G513 G521 10762604 1:CAS:528:DC%2BD3cXis12iu70%3D
13. J Ekblom QS Zhu K Chen JC Shih 1996 Monoamine oxidase gene transcription in human cell lines: treatment with psychoactive drugs and ethanol J Neural Transm 103 681 692 8836930 10.1007/BF01271228 1:CAS:528:DyaK28Xltlantbg%3D (Pubitemid 26383924)
14. C Fang KO Lindros TM Badger MJ Ronis M Ingelman-Sundberg 1998 Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole Hepatology 27 1304 1310 9581684 10.1002/hep.510270516 1:CAS:528:DyaK1cXjtVSjtrg%3D (Pubitemid 28227857)
15. HH Fernandez JJ Chen 2007 Monamine oxidase inhibitors: current and emerging agents for Parkinson disease Clin Neuropharmacol 30 150 168 17545750 10.1097/01.wnf.0000240956.49315.be 1:CAS:528:DC%2BD2sXlvFGkurw%3D (Pubitemid 46871865)
16. ME Fernandez-Zapico A Mladek V Ellenrieder E Folch-Puy L Miller R Urrutia 2003 An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation EMBO J 22 4748 4758 12970187 10.1093/emboj/cdg470 1:CAS:528:DC%2BD3sXnt1Kjtr0%3D (Pubitemid 37162911)
17. RM Geha I Rebrin K Chen JC Shih 2001 Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid J Biol Chem 276 9877 9882 11134050 10.1074/jbc.M006972200 1:CAS:528:DC%2BD3MXis1Oksrs%3D
18. Gerlach M, Double KL, Youdim MB, Riederer P (2006) Potential sources of increased iron in the substantia nigra of parkinsonian patients. J Neural Transm Suppl (70):133-142
19. PJ Goodnick 2007 Seligiline transdermal system in depression Expert Opin Pharmacother 8 59 64 17163807 10.1517/14656566.8.1.59 1:CAS:528: DC%2BD28XhtlSrsLzN (Pubitemid 46070829)
20. MR Hara N Agrawal SF Kim MB Cascio M Fujimuro Y Ozeki M Takahashi JH Cheah SK Tankou LD Hester CD Ferris SD Hayward SH Snyder A Sawa 2005 S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding Nat Cell Biol 7 665 674 15951807 10.1038/ncb1268 1:CAS:528:DC%2BD2MXlslWht7c%3D (Pubitemid 40975747)
21. MR Hara B Thomas MB Cascio BI Bae LD Hester VL Dawson TM Dawson A Sawa SH Snyder 2006 Neuroprotection by pharmacologic blockade of the GAPDH death cascade Proc Natl Acad Sci U S A 103 3887 3889 16505364 10.1073/pnas.0511321103 1:CAS:528:DC%2BD28XivFWisbs%3D (Pubitemid 43376650)
22. JH Henriksen M Gronbaek S Moller F Bendtsen U Becker 1997 Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: a kinetic study J Hepatol 26 287 292 9059948 10.1016/S0168-8278(97)80043-8 1:STN:280:DyaK2s3htlWrsQ%3D%3D (Pubitemid 27077426)
23. Y Li P Nowotny P Holmans S Smemo JS Kauwe AL Hinrichs K Tacey L Doil R van Luchene V Garcia C Rowland S Schrodi D Leong G Gogic J Chan A Cravchik D Ross K Lau S Kwok SY Chang J Catanese J Sninsky TJ White J Hardy J Powell S Lovestone JC Morris L Thal M Owen J Williams A Goate A Grupe 2004 Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family Proc Natl Acad Sci U S A 101 15688 15693 15507493 10.1073/pnas.0403535101 1:CAS:528:DC%2BD2cXhtVWisLjO (Pubitemid 39473549)
24. H Liu M Baliga SA Bigler R Baliga 2003 Role of cytochrome P450 2B1 in puromycin aminonucleoside-induced cytotoxicity to glomerular epithelial cells Nephron Exp Nephrol 94 e17 e24 12806184 10.1159/000070815 1:CAS:528: DC%2BD3sXksFWltbY%3D
25. D Lu C Johnson S Johnson S Tazik XM Ou 2008 The neuroprotective effect of antidepressant drug via inhibition of TIEG2-MAO B mediated cell death Drug Discov Ther 2 289 295
26. J Luo MW Miller 1996 Ethanol inhibits basic fibroblast growth factor-mediated proliferation of C6 astrocytoma cells J Neurochem 67 1448 1456 8858926 1:CAS:528:DyaK28XmtVWit78%3D
27. J Luo MW Miller 1997 Differential sensitivity of human neuroblastoma cell lines to ethanol: correlations with their proliferative responses to mitogenic growth factors and expression of growth factor receptors Alcohol Clin Exp Res 21 1186 1194 9347077 1:CAS:528:DyaK2sXnt1Ols78%3D
28. W Maruyama Y Akao MB Youdim BA Davis M Naoi 2001 Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol J Neurochem 78 727 735 11520893 10.1046/j.1471-4159.2001.00448.x 1:CAS:528:DC%2BD3MXmt1egs70%3D (Pubitemid 32777974)
29. XM Ou PM Partoens JM Wang JH Walker K Danks PF Vaughan WP De Potter 1998 The storage of noradrenaline, neuropeptide Y and chromogranins in and stoichiometric release from large dense cored vesicles of the undifferentiated human neuroblastoma cell line SH-SY5Y Int J Mol Med 1 105 112 9852206 1:CAS:528:DyaK1cXht1OhtA%3D%3D
30. XM Ou K Chen JC Shih 2004 Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine oxidase (MAO) B gene J Biol Chem 279 21021 21028 15024015 10.1074/jbc.M312638200 1:CAS:528: DC%2BD2cXjvV2ntro%3D (Pubitemid 38656503)
31. XM Ou K Chen JC Shih 2006 Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway Proc Natl Acad Sci U S A 103 10923 10928 16829576 10.1073/pnas.0601515103 1:CAS:528:DC%2BD28XnsFensb4%3D (Pubitemid 44148396)
32. XM Ou K Chen JC Shih 2006 Glucocorticoid and androgen activation of monoamine oxidase A are regulated differently by R1 and SP1 J Biol Chem 29 54
33. NJ Pantazis DP Dohrman J Luo CR Goodlett JR West 1992 Alcohol reduces the number of pheochromocytoma (PC12) cells in culture Alcohol 9 171 180 1605882 10.1016/0741-8329(92)90048-F 1:CAS:528:DyaK38XltVKju7w%3D
34. IA Paterson AJ Barber DL Gelowitz C Voll 1997 (-)Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells Neurosci Biobehav Rev 21 181 186 9062941 10.1016/S0149-7634(96)00008-5 1:CAS:528:DyaK2sXitFWgu78%3D (Pubitemid 27102563)
35. DS Robinson JD Amsterdam 2008 The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability J Affect Disord 105 15 23 17568687 10.1016/j.jad.2007.04.024 1:CAS:528:DC%2BD2sXhsVelt7zN (Pubitemid 350236356)
36. VV Senatorov V Charles PH Reddy DA Tagle DM Chuang 2003 Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington's disease Mol Cell Neurosci 22 285 297 12691731 10.1016/S1044-7431(02)00013-1 1:CAS:528:DC%2BD3sXis1yqt7w%3D (Pubitemid 36407592)
37. JC Shih K Chen MJ Ridd 1999 Monoamine oxidase: from genes to behavior Annu Rev Neurosci 22 197 217 10202537 10.1146/annurev.neuro.22.1.197 1:CAS:528:DyaK1MXhvFemsrk%3D (Pubitemid 29144886)
38. Z Speiser R Levy S Cohen 1998 Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders J Neural Transm Suppl 52 287 300 9564629 1:CAS:528:DyaK1cXjtlSjtLw%3D
39. PN Tariot RM Cohen T Sunderland PA Newhouse D Yount AM Mellow H Weingartner EA Mueller DL Murphy 1987 L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition Arch Gen Psychiatry 44 427 433 3107514 1:STN:280:DyaL2s3ht1ekug%3D%3D
40. WG Tatton WY Ju DP Holland C Tai M Kwan 1994 (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis J Neurochem 63 1572 1575 7931312 1:CAS:528:DyaK2cXmt1WrsLg%3D
41. WG Tatton RM Chalmers-Redman M Elstner W Leesch FB Jagodzinski DP Stupak MM Sugrue NA Tatton 2000 Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling J Neural Transm Suppl 7 7 100
42. W Tatton R Chalmers-Redman N Tatton 2003 Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B J Neural Transm 110 509 515 12721812 10.1007/s00702-002- 0827-z 1:CAS:528:DC%2BD3sXjt1OmurY%3D (Pubitemid 36543282)
43. CL Wang YL Wan YC Liu ZQ Huang 2006 TGF-beta1/SMAD signaling pathway mediates p53-dependent apoptosis in hepatoma cell lines Chin Med Sci J 21 33 35 16615282
44. WK Wong K Chen JC Shih 2001 Regulation of human monoamine oxidase B gene by Sp1 and Sp3 Mol Pharmacol 59 852 859 11259630 1:CAS:528:DC%2BD3MXisVSqs7s%3D
45. Z Yao J Zhang J Dai ET Keller 2001 Ethanol activates NFkappaB DNA binding and p56lck protein tyrosine kinase in human osteoblast-like cells Bone 28 167 173 11182374 10.1016/S8756-3282(00)00425-7 1:CAS:528:DC%2BD3MXhtFehu7o%3D (Pubitemid 32140972)
46. MB Youdim 2006 The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30 Curr Alzheimer Res 3 541 550 17168653 10.2174/156720506779025288 1:CAS:528:DC%2BD28XhtlWksbrF (Pubitemid 46066429)
47. MB Youdim A Wadia W Tatton M Weinstock 2001 The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo Ann N Y Acad Sci 939 450 458 11462801 1:CAS:528:DC%2BD3MXlsV2ksbo%3D
48. MB Youdim W Maruyama M Naoi 2005 Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor anti-parkinsonian drug, rasagiline Drugs Today (Barc) 41 369 391 10.1358/dot.2005.41.6.893613 1:CAS:528:DC%2BD2MXpsFGls7s%3D (Pubitemid 41078802)
49. JS Zhang MC Moncrieffe J Kaczynski V Ellenrieder FG Prendergast R Urrutia 2001 A conserved alpha-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A Mol Cell Biol 21 5041 5049 11438660 10.1128/MCB.21.15.5041-5049.2001 1:CAS:528:DC%2BD3MXlsVGitL8%3D (Pubitemid 32656401)